Astec Lifesciences informs about statement of investor complaints

18 Oct 2017 Evaluate

Astec Lifesciences has informed about Statement of Investor Complaints as per Regulation 13(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the Quarter ended 30th September, 2017.

The above information is a part of company’s filings submitted to BSE.

Astec Lifesciences Share Price

717.25 -44.20 (-5.80%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
UPL 739.80
PI Industries 3329.35
Bayer CropScience 4435.00
Sharda Cropchem 849.50
Sumitomo Chemical 452.85
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×